Procyon Advisors
CME icon

Procyon Advisors’s CME Group CME Stock Holding History

Procyon Advisors’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.44M Sell
9,319
-3,956
-30% -$1.04M 0.1% 184
2026
Q2 		$2.93M Sell
13,275
-822
-6% -$227K 0.13% 150
2026
Q1 		$4.16M Sell
14,097
-421
-3% -$125K 0.2% 111
2025
Q4 		$3.96M Sell
14,518
-289
-2% -$78.5K 0.2% 107
2025
Q3 		$4M Sell
14,807
-2,405
-14% -$654K 0.24% 83
2025
Q2 		$4.74M Sell
17,212
-1,517
-8% -$413K 0.44% 51
2025
Q1 		$4.97M Buy
18,729
+777
+4% +$192K 0.3% 78
2024
Q4 		$4.17M Sell
17,952
-2,607
-13% -$599K 0.26% 86
2024
Q3 		$4.54M Sell
20,559
-1,334
-6% -$276K 0.31% 78
2024
Q2 		$4.3M Buy
21,893
+1,452
+7% +$300K 0.32% 71
2024
Q1 		$4.4M Sell
20,441
-522
-2% -$110K 0.34% 68
2023
Q4 		$4.41M Buy
20,963
+4,679
+29% +$998K 0.38% 60
2023
Q3 		$3.26M Sell
16,284
-1,061
-6% -$211K 0.33% 72
2023
Q2 		$3.21M Buy
17,345
+3,008
+21% +$556K 0.4% 58
2023
Q1 		$2.75M Buy
14,337
+4,348
+44% +$786K 0.46% 48
2022
Q4 		$1.68M Buy
9,989
+4,490
+82% +$780K 0.31% 76
2022
Q3 		$974K Buy
5,499
+889
+19% +$176K 0.24% 97
2022
Q2 		$944K Buy
4,610
+517
+13% +$110K 0.21% 104
2022
Q1 		$973K Buy
4,093
+759
+23% +$178K 0.2% 105
2021
Q4 		$762K Buy
3,334
+1,506
+82% +$331K 0.16% 125
2021
Q3 		$354K Buy
1,828
+142
+8% +$28.8K 0.09% 209
2021
Q2 		$359K Buy
1,686
+384
+29% +$81.1K 0.1% 179
2021
Q1 		$266K Buy
1,302
+203
+18% +$40K 0.12% 195
2020
Q4 		$200K Buy
+1,099
New +$187K 0.1% 223
2020
Q3 		– Sell
-1,016
Closed -$165K – 357
2020
Q2 		$165K Sell
1,016
-181
-15% -$32.4K 0.09% 213
2020
Q1 		$207K Sell
1,197
-1,603
-57% -$319K 0.14% 145
2019
Q4 		$562K Buy
+2,800
New +$574K 0.34% 69

Other funds holding CME

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Procyon Advisors's CME Position: Q3 2026 in Review

Procyon Advisors reduced its CME Group (CME) stake by 30% in Q3 2026, selling an estimated $1.04M and leaving 9,319 shares worth $2.44M. The position accounts for 0.1% of the portfolio, ranked #184.

Procyon Advisors first reported a position in CME in Q4 2019 and has held it in 27 quarters since. The position peaked at $4.97M in Q1 2025. 1,480 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Procyon Advisors held 9,319 shares of CME Group worth $2.44M as of Q3 2026.
  • Procyon Advisors sold 3,956 CME Group shares in Q3 2026, an estimated $1.04M.
  • CME Group made up 0.1% of Procyon Advisors's portfolio in Q3 2026, its #184 holding.
  • Procyon Advisors first reported a position in CME Group in Q4 2019 and has held it in 27 quarters since.
  • Procyon Advisors's CME Group position peaked at $4.97M in Q1 2025.
  • 1,480 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Procyon Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.